GRAPEVINE, Texas, Nov. 08, 2016 -- United Development Funding IV (“UDF IV”) announced today that its board of trustees has authorized a cash distribution of $0.08 per share payable on November 28, 2016 to shareholders of record at the close of business on November 18, 2016.
About United Development Funding IV
United Development Funding IV is a public Maryland real estate investment trust. UDF IV was formed primarily to generate current interest income by investing in secured loans and producing profits from investments in residential real estate. Additional information about UDF IV can be found on its website at www.udfiv.com. UDF IV may disseminate important information regarding its operations, including financial information, through social media platforms such as Twitter, Facebook and LinkedIn.
Investor Contact: Investor Relations 1-800-859-9338 [email protected] Media Contact: Jeff Eller 469-916-4883 [email protected]


Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



